Testosterone abrogates ... contributing to the preservation of a differentiated phenotype

[Patrick OShea]

http://www.ncbi.nlm.nih.gov/pubmed/23280522

[Sam]

Thanks for that one Pat & .. Hey guys "Happy New Year". Sorry I wasn't around for the party but I was taking a break from it all. Stay well all !

Sammy

On Thursday, 3 January 2013 16:14:52 UTC, Patrick wrote:

http://www.ncbi.nlm.nih.gov/pubmed/23280522

[Patrick OShea]

Hi Sammy,

Having lost two guys on NTPC in the past few weeks, albeit from CVD (common in PCa), it's good to hear from the guy once voted "least likely to see 2013 in!"

Let's hope that this year will be a good one.

-Patrick

--
--
Prostate cancer is an exceptionally heterogenous disease. What is good for one man may not be so kind on the next. Be sure to research and test any new supplement or treatment before adopting it - and in any case run it past a medically qualified person for a second opinion.
 
 
 

[Sam]

Hi Pat, thanks for the thoughtful comments. I guess I must have signalled I was a "gonner". But then who knows how long any of us has to go ?

Aside: I note with the passing of both guys on NPT attribued to "CVD" I just wonder how this went down on the official cause, so that statisticians can work out how prevalent PC is, compared to say CVD ?

Ed and Dominic made a great contribution to our knowledge of this terrible disease that afflicts so many men, yet gets so little attention, relatively speaking. Can it be because of such mix-ups as indicated above ?

Well, I'll post again when I find an interesting paper. Fraid I have nothing at the moment except a mouse that howls at the full moon from this weeks' New Scientist.

Cheers,

Sam.

[Patrick OShea]

Hi Sam,

Speaking of mix-ups, it was Duane - not Dominic.

We didn't always agree (e.g. he thought that his T was too high - saliva tests had him above the normal range - while his serum T showed him to be seriously hypogonadal), but he was tireless when it came to tackling his PCa, and always willing to join in a debate.

As far as I know, they will not be counted in PCa mortality stats.  Dr Myers spends a lot of time on CVD risk, & even wonders whether there is a PCa connection.  I think it would be easy to build a case, using studies on PubMed.

Best, -Patrick

 

Dx04 @ 56 (DRE nodule 2002) |bPSA 3.3 (0.8 when nodule found)| GS=4+3, RP - no LN, no SV, but PSA nadir-0.3. DT=3 months Salvage RT 2005. Again, nadir=0.3. No HB. Arimidex. AndroDerm.

---

From: Sam <georgias...@gmail.com>
To: prostatic-dise...@googlegroups.com
Sent: Friday, January 18, 2013 7:43 PM
Subject: Re: [PDT:1271] Re: Testosterone abrogates ... contributing to the preservation of a differentiated phenotype